Ritter Daniher Financial Advisory LLC Vertex Pharmaceuticals Inc Transaction History
Ritter Daniher Financial Advisory LLC
- $313 Million
- Q2 2024
A detailed history of Ritter Daniher Financial Advisory LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ritter Daniher Financial Advisory LLC holds 326 shares of VRTX stock, worth $147,857. This represents 0.05% of its overall portfolio holdings.
Number of Shares
326
Previous 326
-0.0%
Holding current value
$147,857
Previous $136,000
11.76%
% of portfolio
0.05%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,708Shares Held
225MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$12.1 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.67 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.32 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$3.87 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...